Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (166)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Sporn, M. B.
Right arrow Articles by Suh, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sporn, M. B.
Right arrow Articles by Suh, N.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 3, 525-530, March 2000
© 2000 Oxford University Press

Molecular Epidemiology and Cancer Prevention

Chemoprevention of cancer

Michael B. Sporn1 and Nanjoo Suh

Department of Pharmacology, Dartmouth Medical School, Hanover, NH 03755, USA

In this short article, we review the conceptual basis for chemoprevention of cancer, the proven clinical efficacy of this concept, and current trends to develop new chemopreventive agents based on understanding of their mechanisms of action. Four classes of new agents, namely selective inhibitors of cyclooxygenase-2, selective estrogen receptor modulators, rexinoids (retinoids that bind selectively to the receptors known as RXRs) and ligands for the peroxisome proliferator-activated receptor-{gamma} are discussed in detail. The importance of developing totally new classes of chemopreventive agents is stressed, with particular emphasis on the potential usefulness of new synthetic triterpenoids derived from naturally occurring molecules.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
H. Orita, J. Coulter, E. Tully, F. P. Kuhajda, and E. Gabrielson
Inhibiting Fatty Acid Synthase for Chemoprevention of Chemically Induced Lung Tumors
Clin. Cancer Res., April 15, 2008; 14(8): 2458 - 2464.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
Y.-S. Hsieh, S.-C. Chu, S.-F. Yang, P.-N. Chen, Y.-C. Liu, and K.-H. Lu
Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2
Carcinogenesis, May 1, 2007; 28(5): 977 - 987.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Shishodia, G. Sethi, M. Konopleva, M. Andreeff, and B. B. Aggarwal
A Synthetic Triterpenoid, CDDO-Me, Inhibits I{kappa}B{alpha} Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor {kappa}B-Regulated Gene Products in Human Leukemic Cells
Clin. Cancer Res., March 15, 2006; 12(6): 1828 - 1838.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
B. L. Pool-Zobel, V. Selvaraju, J. Sauer, T. Kautenburger, J. Kiefer, K. K. Richter, M. Soom, and S. Wolfl
Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics
Carcinogenesis, June 1, 2005; 26(6): 1064 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J.-L. Su, M.-T. Lin, C.-C. Hong, C.-C. Chang, S.-G. Shiah, C.-W. Wu, S.-T. Chen, Y.-P. Chau, and M.-L. Kuo
Resveratrol induces FasL-related apoptosis through Cdc42 activation of ASK1/JNK-dependent signaling pathway in human leukemia HL-60 cells
Carcinogenesis, January 1, 2005; 26(1): 1 - 10.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
Y. Zhang and G. B. Gordon
A strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
Mol. Cancer Ther., July 1, 2004; 3(7): 885 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Suzui, M. Shimizu, M. Masuda, J. T. E. Lim, N. Yoshimi, and I. B. Weinstein
Acyclic retinoid activates retinoic acid receptor {beta} and induces transcriptional activation of p21CIP1 in HepG2 human hepatoma cells
Mol. Cancer Ther., March 1, 2004; 3(3): 309 - 316.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
A. F. Badawi, M. B. Eldeen, Y. Liu, E. A. Ross, and M. Z. Badr
Inhibition of Rat Mammary Gland Carcinogenesis by Simultaneous Targeting of Cyclooxygenase-2 and Peroxisome Proliferator-activated Receptor {gamma}
Cancer Res., February 1, 2004; 64(3): 1181 - 1189.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
L. Kopelovich, J. A. Crowell, and J. R. Fay
The Epigenome as a Target for Cancer Chemoprevention
J Natl Cancer Inst, December 3, 2003; 95(23): 1747 - 1757.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y. Takada and B. B. Aggarwal
Betulinic Acid Suppresses Carcinogen-Induced NF-{kappa}B Activation Through Inhibition of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Abrogation of Cyclooxygenase-2 and Matrix Metalloprotease-9
J. Immunol., September 15, 2003; 171(6): 3278 - 3286.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. P. Singh, G. Sharma, S. Dhanalakshmi, C. Agarwal, and R. Agarwal
Suppression of Advanced Human Prostate Tumor Growth in Athymic Mice by Silibinin Feeding Is Associated with Reduced Cell Proliferation, Increased Apoptosis, and Inhibition of Angiogenesis
Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 933 - 939.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Shishodia, S. Majumdar, S. Banerjee, and B. B. Aggarwal
Ursolic Acid Inhibits Nuclear Factor-{kappa}B Activation Induced by Carcinogenic Agents through Suppression of I{kappa}B{alpha} Kinase and p65 Phosphorylation: Correlation with Down-Regulation of Cyclooxygenase 2, Matrix Metalloproteinase 9, and Cyclin D1
Cancer Res., August 1, 2003; 63(15): 4375 - 4383.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. K. Vayalil, C. A. Elmets, and S. K. Katiyar
Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin
Carcinogenesis, May 1, 2003; 24(5): 927 - 936.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
D. R. Soprano and K. J. Soprano
Pharmacological Doses of Some Synthetic Retinoids Can Modulate Both the Aryl Hydrocarbon Receptor and Retinoid Receptor Pathways
J. Nutr., January 1, 2003; 133(1): 277S - 281.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. K. Tyagi, R. P. Singh, C. Agarwal, D. C. F. Chan, and R. Agarwal
Silibinin Strongly Synergizes Human Prostate Carcinoma DU145 Cells to Doxorubicin-induced Growth Inhibition, G2-M Arrest, and Apoptosis
Clin. Cancer Res., November 1, 2002; 8(11): 3512 - 3519.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. J. Lindner, X. Ma, J. Hu, S. Karra, and D. V. Kalvakolanu
Thioredoxin Reductase Plays a Critical Role in IFN Retinoid-mediated Tumor-Growth Control in Vivo
Clin. Cancer Res., October 1, 2002; 8(10): 3210 - 3218.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
R. C. Haydon, L. Zhou, T. Feng, B. Breyer, H. Cheng, W. Jiang, A. Ishikawa, T. Peabody, A. Montag, M. A. Simon, et al.
Nuclear Receptor Agonists As Potential Differentiation Therapy Agents for Human Osteosarcoma
Clin. Cancer Res., May 1, 2002; 8(5): 1288 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
R. P. Singh, A. K. Tyagi, J. Zhao, and R. Agarwal
Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis
Carcinogenesis, March 1, 2002; 23(3): 499 - 510.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
C. J. Gambone, J. M. Hutcheson, J. L. Gabriel, R. L. Beard, R. A.S. Chandraratna, K. J. Soprano, and D. R. Soprano
Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway
Mol. Pharmacol., February 1, 2002; 61(2): 334 - 342.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
F. TOSETTI, N. FERRARI, S. DE FLORA, and A. ALBINI
Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents
FASEB J, January 1, 2002; 16(1): 2 - 14.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. Konopleva, T. Tsao, P. Ruvolo, I. Stiouf, Z. Estrov, C. E. Leysath, S. Zhao, D. Harris, S. Chang, C. E. Jackson, et al.
Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia
Blood, January 1, 2002; 99(1): 326 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
R A Sharma, A J Gescher, K J O'Byrne, and W P Steward
Familiar drugs may prevent cancer
Postgrad. Med. J., August 1, 2001; 77(910): 492 - 497.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Ahmad, V. M. Adhami, F. Afaq, D. K. Feyes, and H. Mukhtar
Resveratrol Causes WAF-1/p21-mediated G1-phase Arrest of Cell Cycle and Induction of Apoptosis in Human Epidermoid Carcinoma A431 Cells
Clin. Cancer Res., May 1, 2001; 7(5): 1466 - 1473.
[Abstract] [Full Text]

Home page
 Clin. Cancer Res.Home page
K. Wu, H.-T. Kim, J. L. Rodriquez, D. Munoz-Medellin, S. K. Mohsin, S. G. Hilsenbeck, W. W. Lamph, M. M. Gottardis, M. A. Shirley, J. G. Kuhn, et al.
9-cis-Retinoic Acid Suppresses Mammary Tumorigenesis in C3(1)-Simian Virus 40 T Antigen-transgenic Mice
Clin. Cancer Res., September 1, 2000; 6(9): 3696 - 3704.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
F. P. Guengerich
Metabolism of chemical carcinogens
Carcinogenesis, March 1, 2000; 21(3): 345 - 351.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
F. P. Perera and I.B. Weinstein
Molecular epidemiology: recent advances and future directions
Carcinogenesis, March 1, 2000; 21(3): 517 - 524.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.